-
Signature
-
/s/ Kjelti Kellough, as attorney in fact for Peter Orlowsky
-
Issuer symbol
-
GETY
-
Transactions as of
-
12 Dec 2023
-
Net transactions value
-
-$197,016
-
Form type
-
4
-
Filing time
-
14 Dec 2023, 16:30:23 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
GETY |
Class A Common Stock |
Options Exercise |
$13,099 |
+6,683 |
+3.4% |
$1.96 |
205,496 |
12 Dec 2023 |
Direct |
|
| transaction |
GETY |
Class A Common Stock |
Sale |
$33,682 |
-6,683 |
-3.3% |
$5.04 |
198,813 |
12 Dec 2023 |
Direct |
F1, F2 |
| transaction |
GETY |
Class A Common Stock |
Options Exercise |
$63,645 |
+32,472 |
+16% |
$1.96 |
231,285 |
13 Dec 2023 |
Direct |
|
| transaction |
GETY |
Class A Common Stock |
Sale |
$163,334 |
-32,472 |
-14% |
$5.03 |
198,813 |
13 Dec 2023 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GETY |
Stock Option (Right to Buy) |
Options Exercise |
$13,099 |
-6,683 |
-8.1% |
$1.96 |
76,115 |
12 Dec 2023 |
Class A Common Stock |
6,683 |
$1.96 |
Direct |
F3 |
| transaction |
GETY |
Stock Option (Right to Buy) |
Options Exercise |
$63,645 |
-32,472 |
-43% |
$1.96 |
43,643 |
13 Dec 2023 |
Class A Common Stock |
32,472 |
$1.96 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: